|
       |
 |
Medicine for the Public 2000 lecture seriesVideos of the 2000 lectures, which were presented Tuesdays during September and October, are now online. |
|
|
New therapies. Innovations in diagnostic procedures. How today's research will affect tomorrow's medicine. Physician-scientists working at the forefront of medical research at the National Institutes of Health will examine these issues during 2000's Medicine for the Public lecture series sponsored by the NIH Clinical Center. For details on specific topics and speakers, please call (301) 496-2563. Or e-mail occc@cc.nih.gov. |
The
lectures, which are free and open to the public,are presented
at 7 p.m. on Tuesdays in the Clinical Center's Masur Auditorium,
National Institutes of Health, 9000 Rockville Pike, Building 10, Bethesda,
Maryland. Booklets based on selected Medicine for the Public lectures are available. Visit this site to order or call 301-496-2563. |
|
Videos of these lectures require the latest free version of RealPlayer. |
||
|
Sept.
19, 2000 |
00
|
Dr.
Kirk
will explain how diabetes, renal failure, and other end-stage organ diseases
can be treated more successfully by immunologic strategies that make the
body believe that the transplanted tissues are its own. A surgeon and
authority on organ transplantation, Dr. Kirk will explore new methods
to prevent the rejection of transplanted organs and tissues, and the development
of new drugs or techniques that may improve the success of organ and tissue
transplants.
|
|
Sept.
26, 2000
Adolescents and AIDS: Millennium Milestones Dr. Lauren Wood Senior Clinical Investigator, HIV & AIDS Malignancy Branch National Cancer Institute |
00
|
Unbelievable
progress has been made in the last two decades in the fight against HIV/AIDS,
yet there's still so far to go. Dramatic advances in treatment have resulted
in children born with the virus living into their teens, while at the
same time there has been an alarming surge of HIV infection rates among
adolescents, particularly female adolescents and urban minorities. Dr.
Wood will discuss some of the positive and negative milestones reached
to date, including advances in care and research, as well as the changing
epidemiology of the HIV epidemic.
|
|
Oct.
3, 2000
Dangerous Liaisons: Drugs and Herbal Products Dr. Stephen Piscitelli, Pharmacokineticist and Coordinator and Dr. Aaron Burstein, Pharmacokineticist, Clinical Pharmacokinetics Research Laboratory, Pharmacy Department, NIH Clinical Center |
00
|
Everyday,
as more Americans begin using herbal products, how many actually consider
the risks? Drs. Piscitelli and
Burstein will describe the widespread
use of complementary medicines in the United States, focusing on the benefits
and dangers of herbal products. Potential interactions between herbs and
prescription drugs, as well as severe side effects of some well-known
products will be addressed. Attendees will also learn about regulations
pertaining to herbal products and what consumers should know when considering
herbal use.
|
|
Oct.
10, 2000
Stroke: Rapid Diagnosis, New Treatments Dr. Alison Baird Visiting Scientist, Section on Stroke Diagnostics and Therapeutics National Institute of Neurological Disorders and Stroke |
00
|
Brain
attack--stroke--strikes every 43 seconds. It's the third leading cause
of death in this country and often results in devastating physical disability
for survivors. Rapid diagnosis is crucial for successful treatment. Dr.
Baird will discuss advances in how physicians use innovative imaging
technology to confirm strokes and new options to treat them.
|
|
Oct.
17, 2000
Women's Health Research for the 21st Century Dr. Vivian Pinn NIH Associate Director for Research on Women's Health Director, NIH Office of Research on Women's Health |
00
|
The
NIH Office of Research on Women's Health was established 10 years ago
to assure that research conducted and supported by NIH addresses issues
regarding women's health and that there is appropriate participation of
women in clinical trials. Dr. Pinn
will discuss current status and future direction of women's health research.
|
|
Oct.
24, 2000 |
00
|
Drs.
Linehan and Dahut will outline risk
factors for prostate cancer and how the disease develops. They will also
look at new treatments now under investigation, including vaccine therapy,
hormonal therapy, anti-angiogenic therapy and chemotherapy for advanced
and recurrent prostate cancer.
|
Past lectures:
2005 | 2004 |
2003 | 2002 |
2001 | 2000 |
1999 | 1998 |
1997
Back to most current lectures
For
more information about the Clinical Center,
e-mail occc@cc.nih.gov, or call
Clinical Center Communications, 301-496-2563.
Warren
Grant Magnuson Clinical Center
National Institutes of Health
Bethesda, Maryland 20892-7511
